Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections of the Upper Respiratory Tract”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05128643
What this trial is testing

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT06614725
What this trial is testing

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 751
Early research (Phase 1)Study completedNCT06342349
What this trial is testing

A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 300
Testing effectiveness (Phase 2)Study completedNCT07204964
What this trial is testing

Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

Who this might be right for
Influenza, Human
GlaxoSmithKline 971
Not applicableStudy completedNCT05406180
What this trial is testing

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above

Who this might be right for
Influenza
Sanofi 675
Large-scale testing (Phase 3)UnknownNCT04548518
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly

Who this might be right for
Influenza
Mahidol University 816
Testing effectiveness (Phase 2)Study completedNCT04341389
What this trial is testing

A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)

Who this might be right for
COVID-19
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China 508
Early research (Phase 1)Active Not RecruitingNCT06645665
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 240
Large-scale testing (Phase 3)Study completedNCT03314662
What this trial is testing

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Who this might be right for
Influenza, Human
Seqirus 1,778
Early research (Phase 1)Active Not RecruitingNCT06622590
What this trial is testing

Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Influenza, HumanInfluenza aInfluenza Type B+1 more
Institute of Medical Biology, Chinese Academy of Medical Sciences 180
Large-scale testing (Phase 3)Ended earlyNCT05012787
What this trial is testing

Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 1
Testing effectiveness (Phase 2)Ended earlyNCT04056611
What this trial is testing

Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Sciences Ireland UC 3
Testing effectiveness (Phase 2)Looking for participantsNCT07779408
What this trial is testing

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Who this might be right for
Healthy VolunteersInfluenza
Sanofi 640
Testing effectiveness (Phase 2)Ended earlyNCT05520970
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 4
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Large-scale testing (Phase 3)UnknownNCT05664932
What this trial is testing

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT05308212
What this trial is testing

Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra

Who this might be right for
Influenza
St. Petersburg Research Institute of Vaccines and Sera 633
Testing effectiveness (Phase 2)UnknownNCT05365724
What this trial is testing

Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 280
Testing effectiveness (Phase 2)Study completedNCT05043259
What this trial is testing

Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming with an Inactivated SARS-CoV-2 Vaccine

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 423
Large-scale testing (Phase 3)Study completedNCT04780035
What this trial is testing

Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

Who this might be right for
COVID-19
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 3,000
Next Page